A Combretastatin-Mediated Decrease in Neutrophil Concentration in Peripheral Blood and the Impact on the Anti-Tumor Activity of This Drug in Two Different Murine Tumor Models

• Anja Bille Bohn,

  Affiliation Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Thomas Wittenborn,

  Affiliation Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Anne Sofie Brems-Eskildsen,

  Affiliation Department of Pathology, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Tinne Laurberg,

  Affiliation Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Lotte Bonde Bertelsen,

  Affiliation The MR-Research Centre, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Thomas Nielsen,

  Affiliation Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Hans Stødkilde-Jørgensen,

  Affiliation The MR-Research Centre, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Bjarne Kuno Møller,

  Affiliation Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Michael R. Horsman

  * E-mail: mike@oncology.dk

  Affiliation Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

  ⨯